Cutaneous IgE‐mediated inflammatory lesion size is inhibited by an H1 antagonist (terfenadine) while mediator release is unaffected in vivo and in vitro
Authors:
- 1 May 1993
- journal article
- clinical trial
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 23 (5) , 399-405
Abstract
Summary: We are interested in understanding the pathogenesis of the cutaneous IgE‐mediated late phase reaction. A double‐blind, placebo‐controlled, randomized cross‐over study with 10 subjects of the effect of the non‐sedating antihistamine, terfenadine (Selddane), on the cutaneous reaction to antigen (ragweed or mixed grass) administered intradermally and over denuded blister bases was performed. The activity of terfenadine on anti‐IgE‐induced mediator release from the skin mast cell, lung mast cell and basophil was also examined in vitro. Terfenadine significantly inhibited the size of the cutaneous reaction at every hour between hours 1 and 9 (hr 9, control 2250 ± 500 mm2vs drug 1250 ± 250 mm2, P < 0.01, n=10) and showed some inhibitory effect at hours 10–12. While terfenadine blocks histamine release after nasal antigen challenge the release of mediators at skin blister sites was unaffected. The infiltration of leucocytes into the blister supernatant was unaffected by terfenadine although previous studies have shown significant inhibition with another antihistamine, cetirizine. In vitro, terfenadine. like other antihistamines, was found to have inhibitory activity on anti‐IgE‐induced mediator release at concentrations of 10−4‐10−5 M in lung and skin mast cells and basophils. We conclude that the effects of the newer antihistamines on cellular movement into the skin may be diverse, that terfenadine may show organ specificity in vivo and that terfenadine significantly decreases both the early and late gross inflammatory response of the skin to antigen. We cannot, as yet. explain the mechanism(s) by which this occurs.Keywords
This publication has 35 references indexed in Scilit:
- Profile of prostanoid release following antigen challenge in vivo in the skin of manBritish Journal of Dermatology, 1991
- Effect of H1-receptor blockade on late cutaneous reactions to antigen: A double-blind, controlled studyJournal of Allergy and Clinical Immunology, 1991
- Determinants of in vivo histamine release in cutaneous allergic reactions in humansJournal of Allergy and Clinical Immunology, 1990
- Interactions between histamine and prostanoids in IgE-dependent, late cutaneous reactions in manJournal of Allergy and Clinical Immunology, 1990
- Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluationJAMA, 1986
- A novel double-isotope technique for the enzymatic assay of plasma histamine: application to estimation of mast cell activation assessed by antigen challenge in asthmaticsJournal of Allergy and Clinical Immunology, 1982
- Effect in Man of Anti‐Allergic Drugs on the Immediate and Late Phase Cutaneous Allergic Reactions Induced by Anti‐IgEAllergy, 1981
- An evaluation of the pharmacologic inhibition of the immediate and late cutaneous reaction to allergenJournal of Allergy and Clinical Immunology, 1980
- Histologic studies of human skin test responses to ragweed, compound , and histamineJournal of Allergy and Clinical Immunology, 1973
- Antihistaminic properties of local anesthetics and anesthetic properties of antihistaminic compoundsJournal of Allergy, 1951